Expansion for Renfrewshire facility
Scots medical plant secures £33m Tokyo backing
Expansion confirmed at Renfrewshire plant
Tokyo-based Terumo Corporation has unveiled a £33 million investment in expanding its medical device subsidiary Vascutek, near Glasgow.
Vascutek produces implants for sufferers of aortic disease and has helped save or improve the lives of more than two million patients in more than 100 countries.
The investment will be used to scale up existing facilities at the Inchinnan plant, including two new clean rooms and equipment for a new sterilisation suite.
Terumo Corporation was founded in 1921 and has more than 22,000 employees worldwide. It acquired Vascutek in 2002.
Paul Holbrook, president and CEO at Vascutek, said: “This is an extremely exciting time for the company as we look to secure further growth in the surgical grafts market.
“The investment from Terumo is testament to the quality, efficiency and excellent customer service delivered consistently by our team at Inchinnan and will allow us to further expand our business globally.
“The decision to invest in our manufacturing facilities sends a strong signal about the health of our company and our prospects for the future. It is an important milestone in our mission to create innovative products to the highest standard that benefit the lives of patients and their families across the world.”
Established in 1982, Vascutek employs around 800 staff at its Inchinnan base. It applies advanced and innovative technologies to develop its products.
In the UK, the company has been granted 8 ‘Queen’s Awards for Enterprise’, with the most recent in 2016 for Innovation.